About: Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.35 (-2.49%)
TARA NASDAQ Protara Therapeutics Inc
Protara Therapeutics Inc share price
TARA price activity
Last Price
$2.350
Change (24hr)
-0.06 USD (2.49%)
Volume
351.98K
Volume (4w avg)
-
Open
$2.39
Day Range
$2.34 - $2.54
Previous Close
$2.41
Last Trade
04 Nov, 9:25 pm GMT+0
Delayed
04 Nov, 9:25 pm GMT+0
TARA price performance
Delayed
04 Nov, 9:25 pm GMT+0
TARA details
TARA Market Signals